arrow
T

Tobias Nordström

department of medical epidemiology and biostatistics
H指数:31
被引数:5,450

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Detectable prostate-specific antigen after radiotherapy for clinically localized prostate cancer

放射治疗后可检测到的前列腺特异性抗原,用于临床局限性前列腺癌

Cancer
IF5.1
2025-08-170
OAAI
Prostate-specific Antigen Density as a Selection Tool Before Magnetic Resonance Imaging in Prostate Cancer Screening: An Analysis from the STHLM3MRI Randomized Clinical Trial

前列腺特异性抗原密度作为磁共振成像前前列腺癌筛查的筛选工具:来自STHLM3MRI随机临床试验的分析

2025-07-290
OAAI
Epidemiology of High-risk Biochemical Recurrence After Primary Prostate Cancer Treatment

高危生化复发在前列腺癌初次治疗后的流行病学

2025-06-010
OAAI
Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort study

评估现有工具预测临床显著前列腺癌的性能(针对在双参数MRI上呈现不确定病变的男性)及新型多重模型的发展:一项前瞻性队列研究

2025-04-010
OAAI
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
2024-03-121
OAAI
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

通过多祖先全基因组发现187种新的风险变异来表征前列腺癌风险

2023-11-0928
OA
Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging- detected Prostate Imaging Reporting and Data System/Likert >3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score
2022-11-0115
OA